|
1
|
Darnell JE Jr: Transcription factors as
targets for cancer therapy. Nat Rev Cancer. 2:740–749. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Verbiest T, Bouffler S, Nutt SL and Badie
C: PU.1 downregulation in murine radiation-induced acute myeloid
leukaemia (AML): From molecular mechanism to human AML.
Carcinogenesis. 36:413–419. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Scott EW, Simon MC, Anastasi J and Singh
H: Requirement of transcription factor PU.1 in the development of
multiple hematopoietic lineages. Science. 265:1573–1577. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McKercher SR, Torbett BE, Anderson KL,
Henkel GW, Vestal DJ, Baribault H, Klemsz M, Feeney AJ, Wu GE,
Paige CJ and Maki RA: Targeted disruption of the PU.1 gene results
in multiple hematopoietic abnormalities. EMBO J. 15:5647–5658.
1996.PubMed/NCBI
|
|
5
|
Iwasaki H, Somoza C, Shigematsu H, Duprez
EA, Iwasaki-Arai J, Mizuno S, Arinobu Y, Geary K, Zhang P, Dayaram
T, et al: Distinctive and indispensable roles of PU.1 in
maintenance of hematopoietic stem cells and their differentiation.
Blood. 106:1590–1600. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Torlakovic EE, Bilalovic N, Golouh R,
Zidar A and Angel S: Prognostic significance of PU.1 in follicular
lymphoma. J Pathol. 209:352–359. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bonadies N, Pabst T and Mueller BU:
Heterozygous deletion of the PU.1 locus in human AML. Blood.
115:331–334. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huskova H, Korecka K, Karban J, Vargova J,
Vargova K, Dusilkova N, Trneny M and Stopka T: Oncogenic
microRNA-155 and its target PU.1: An integrative gene expression
study in six of the most prevalent lymphomas. Int J Hematol.
102:441–450. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou J, Wu J, Li B, Liu D, Yu J, Yan X,
Zheng S, Wang J, Zhang L, Zhang L, et al: PU.1 is essential for MLL
leukemia partially via crosstalk with the MEIS/HOX pathway.
Leukemia. 28:1436–1448. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
de Boer J, Walf-Vorderwülbecke V and
Williams O: In focus: MLL-rearranged leukemia. Leukemia.
27:1224–1228. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Krivtsov AV and Armstrong SA: MLL
translocations, histone modifications and leukaemia stem-cell
development. Nat Rev Cancer. 7:823–833. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Toda Y, Tsukada J, Misago M, Kominato Y,
Auron PE and Tanaka Y: Autocrine induction of the human
pro-IL-1beta gene promoter by IL-1beta in monocytes. J Immunol.
168:1984–1991. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dolecek TA, Propp JM, Stroup NE and
Kruchko C: CBTRUS statistical report: Primary brain and central
nervous system tumors diagnosed in the United States in 2005–2009.
Neuro Oncol. 14 Suppl 5:v1–v49. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Phillips HS, Kharbanda S, Chen R, Forrest
WF, Soriano RH, Wu TD, Misra A, Nigro JM, Colman H, Soroceanu L, et
al: Molecular subclasses of high-grade glioma predict prognosis,
delineate a pattern of disease progression, and resemble stages in
neurogenesis. Cancer Cell. 9:157–173. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sottoriva A, Spiteri I, Piccirillo SG,
Touloumis A, Collins VP, Marioni JC, Curtis C, Watts C and Tavaré
S: Intratumor heterogeneity in human glioblastoma reflects cancer
evolutionary dynamics. Proc Natl Acad Sci USA. 110:pp. 4009–4014.
2013; View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Charles NA, Holland EC, Gilbertson R,
Glass R and Kettenmann H: The brain tumor microenvironment. Glia.
59:1169–1180. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li W and Graeber MB: The molecular profile
of microglia under the influence of glioma. Neuro Oncol.
14:958–978. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu F, Ku MC, Markovic Da Dzaye OD,
Lehnardt S, Synowitz M, Wolf SA and Kettenmann H: Glioma-associated
microglial MMP9 expression is upregulated by TLR2 signaling and
sensitive to minocycline. Int J Cancer. 135:2569–2578. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pyonteck SM, Akkari L, Schuhmacher AJ,
Bowman RL, Sevenich L, Quail DF, Olson OC, Quick ML, Huse JT,
Teijeiro V, et al: CSF-1R inhibition alters macrophage polarization
and blocks glioma progression. Nat Med. 19:1264–1272. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Markovic DS, Vinnakota K, van Rooijen N,
Kiwit J, Synowitz M, Glass R and Kettenmann H: Minocycline reduces
glioma expansion and invasion by attenuating microglial MT1-MMP
expression. Brain Behav Immun. 25:624–628. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yuan JX and Munson JM: Quantitative
immunohistochemistry of the cellular microenvironment in patient
glioblastoma resections. J Vis Exp. 2017. View Article : Google Scholar
|
|
23
|
Cancer Genome Atlas Research Network, .
Comprehensive genomic characterization defines human glioblastoma
genes and core pathways. Nature. 455:1061–1068. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Poon H, Quirk C, DeZiel C and Heckerman D:
Literome: PubMed-scale genomic knowledge base in the cloud.
Bioinformatics. 30:2840–2842. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Poon H, Toutanova K and Quirk C: Distant
supervision for cancer pathway extraction from text. Pac Symp
Biocomput. 1–131. 2015.PubMed/NCBI
|
|
26
|
Müller S, Sideras P, Smith CI and
Xanthopoulos KG: Cell specific expression of human Bruton's
agammaglobulinemia tyrosine kinase gene (Btk) is regulated by Sp1-
and Spi-1/PU.1-family members. Oncogene. 13:1955–1964.
1996.PubMed/NCBI
|
|
27
|
Starck J, Doubeikovski A, Sarrazin S,
Gonnet C, Rao G, Skoultchi A, Godet J, Dusanter-Fourt I and Morle
F: Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in
inhibition of erythroid differentiation in friend erythroleukemic
cell lines. Mol Cell Biol. 19:121–135. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cinque S, Willems J, Depraetere S,
Vermeire L and Joniau M: ‘In vitro’ effect of interleukin-1 beta on
human glioma cell lines: Regulation of cell proliferation and IL-6
production. Immunol Lett. 34:267–271. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kaplitt MG, Tjuvajev JG, Leib DA, Berk J,
Pettigrew KD, Posner JB, Pfaff DW, Rabkin SD and Blasberg RG:
Mutant herpes simplex virus induced regression of tumors growing in
immunocompetent rats. J Neurooncol. 19:137–147. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sahin A, Vercamer C, Kaminski A, Fuchs T,
Florin A, Hahne JC, Mattot V, Pourtier-Manzanedo A, Pietsch T,
Fafeur V and Wernert N: Dominant-negative inhibition of Ets 1
suppresses tumor growth, invasion and migration in rat C6 glioma
cells and reveals differentially expressed Ets 1 target genes. Int
J Oncol. 34:377–389. 2009.PubMed/NCBI
|
|
31
|
Croft D, Mundo AF, Haw R, Milacic M,
Weiser J, Wu G, Caudy M, Garapati P, Gillespie M, Kamdar MR, et al:
The reactome pathway knowledgebase. Nucleic Acids Res. 42(Database
issue): D472–D477. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Fabregat A, Sidiropoulos K, Garapati P,
Gillespie M, Hausmann K, Haw R, Jassal B, Jupe S, Korninger F,
McKay S, et al: The reactome pathway knowledgebase. Nucleic Acids
Res. 44:D481–D487. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Auron PE, Webb AC, Rosenwasser LJ, Mucci
SF, Rich A, Wolff SM and Dinarello CA: Nucleotide sequence of human
monocyte interleukin 1 precursor cDNA. Proc Natl Acad Sci USA.
81:pp. 7907–7911. 1984; View Article : Google Scholar : PubMed/NCBI
|
|
34
|
March CJ, Mosley B, Larsen A, Cerretti DP,
Braedt G, Price V, Gillis S, Henney CS, Kronheim SR, Grabstein K,
et al: Cloning, sequence and expression of two distinct human
interleukin-1 complementary DNAs. Nature. 315:641–647. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Masters SL, Simon A, Aksentijevich I and
Kastner DL: Horror autoinflammaticus: The molecular pathophysiology
of autoinflammatory disease (*). Annu Rev Immunol. 27:621–668.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhang L, Alizadeh D, Van Handel M,
Kortylewski M, Yu H and Badie B: Stat3 inhibition activates tumor
macrophages and abrogates glioma growth in mice. Glia.
57:1458–1467. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Munkley J, Livermore K, Rajan P and
Elliott DJ: RNA splicing and splicing regulator changes in prostate
cancer pathology. Hum Genet. 136:1143–1154. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Croft D, O'Kelly G, Wu G, Haw R, Gillespie
M, Matthews L, Caudy M, Garapati P, Gopinath G, Jassal B, et al:
Reactome: A database of reactions, pathways and biological
processes. Nucleic Acids Res. 39(Database issue): D691–D697. 2011.
View Article : Google Scholar : PubMed/NCBI
|
